• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有心脏病的女性的严重孕产妇发病率和接近死亡事件:一项队列研究的见解

Severe Maternal Morbidity and near Miss-Events in Women with Heart Disease: Insights from a Cohort Study.

作者信息

Campanharo Felipe Favorette, Araujo Júnior Edward, Born Daniel, Callado Gustavo Yano, Santana Eduardo Félix Martins, Sun Sue Yazaki, Mattar Rosiane

机构信息

Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.

Department of Cardiology, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil.

出版信息

Diagnostics (Basel). 2025 Jun 16;15(12):1524. doi: 10.3390/diagnostics15121524.

DOI:10.3390/diagnostics15121524
PMID:40564847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192550/
Abstract

The maternal mortality ratio is one of the global health indicators, and cardiopathies are the leading indirect causes of maternal deaths. Proper management of pregnant women with heart disease is crucial, as the severity of these conditions can lead to complications during the perinatal period. This study aimed to evaluate the rate of severe maternal morbidity and associated factors in pregnant women with heart disease. A retrospective cohort study was conducted at a referral hospital in São Paulo from 2008 to 2017, including pregnant women with heart disease who underwent procedures in the obstetric center ( = 345). Sociodemographic, obstetric, and pre-existing conditions were analyzed, along with life-threatening conditions, near-miss events, and maternal deaths. Heart diseases were classified according to the World Health Organization (WHO) guidelines, and health indicators were calculated using WHO-recommended formulas. The Chi-square test or Likelihood Ratio test ( < 0.05) was used to compare severe maternal morbidity among women with heart disease. The mean age of participants was 29.1 ± 7.29 years; most were white (58.8%), had completed high school (37.9%), and were married (71.6%). The most frequent pre-existing conditions were hypertension (9.6%) and diabetes mellitus (9.3%). The mean gestational age at admission/delivery was 37 weeks. According to the WHO classification, most women were classified as "II/III" (31.6%). Life-threatening conditions included hemorrhagic complications (13.9%), hypertensive complications (5.8%), clinical complications (19.7%), and severe management conditions (31.6%). Near-miss events occurred in 6.4% of patients, with clinical criteria in 2.9%, laboratory criteria in 4.3%, and management criteria in 3.5%. The cesarean section rate was 51%. Patients classified as WHO III and IV presented more severe management conditions ( < 0.0001), and those in WHO IV had a higher occurrence of near-miss events ( = 0.0001). Maternal mortality was 0.9% ( = 3). The incidence of severe maternal morbidity was 25 cases (22 near-miss events + 3 maternal deaths), equivalent to 2.86 per 1000 live births, and was significantly associated with WHO classifications III and IV.

摘要

孕产妇死亡率是全球卫生指标之一,心脏病是孕产妇死亡的主要间接原因。对患有心脏病的孕妇进行妥善管理至关重要,因为这些病症的严重程度可能导致围产期出现并发症。本研究旨在评估患有心脏病的孕妇发生严重孕产妇发病的比率及相关因素。2008年至2017年在圣保罗的一家转诊医院进行了一项回顾性队列研究,纳入在产科中心接受手术的患有心脏病的孕妇(n = 345)。分析了社会人口统计学、产科和既往病症,以及危及生命的情况、接近死亡事件和孕产妇死亡情况。根据世界卫生组织(WHO)指南对心脏病进行分类,并使用WHO推荐的公式计算健康指标。采用卡方检验或似然比检验(P < 0.05)比较患有心脏病的女性中严重孕产妇发病情况。参与者的平均年龄为29.1±7.29岁;大多数为白人(58.8%),完成高中学业(37.9%),已婚(71.6%)。最常见的既往病症是高血压(9.6%)和糖尿病(9.3%)。入院/分娩时的平均孕周为37周。根据WHO分类,大多数女性被归类为“II/III”(31.6%)。危及生命的情况包括出血并发症(13.9%)、高血压并发症(5.8%)、临床并发症(19.7%)和严重管理情况(31.6%)。6.4%的患者发生了接近死亡事件,其中临床标准占2.9%,实验室标准占4.3%,管理标准占3.5%。剖宫产率为51%。被归类为WHO III和IV的患者出现更严重的管理情况(P < 0.0001),而WHO IV的患者发生接近死亡事件的发生率更高(P = 0.0001)。孕产妇死亡率为0.9%(n = 3)。严重孕产妇发病的发生率为25例(22例接近死亡事件 + 3例孕产妇死亡),相当于每1000例活产中有2.86例,并且与WHO分类III和IV显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/12192550/f468e3dc7886/diagnostics-15-01524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/12192550/f468e3dc7886/diagnostics-15-01524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/12192550/f468e3dc7886/diagnostics-15-01524-g001.jpg

相似文献

1
Severe Maternal Morbidity and near Miss-Events in Women with Heart Disease: Insights from a Cohort Study.患有心脏病的女性的严重孕产妇发病率和接近死亡事件:一项队列研究的见解
Diagnostics (Basel). 2025 Jun 16;15(12):1524. doi: 10.3390/diagnostics15121524.
2
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.孕34周直至足月时高血压疾病的计划早产与期待治疗对比
Cochrane Database Syst Rev. 2017 Jan 15;1(1):CD009273. doi: 10.1002/14651858.CD009273.pub2.
3
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.在足月或接近足月时计划分娩,以改善患有妊娠期糖尿病的孕妇及其婴儿的健康结局。
Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012910. doi: 10.1002/14651858.CD012910.
4
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
5
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.孕前患有糖尿病的女性孕期血糖监测技术。
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
6
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
7
Discontinuation of intravenous oxytocin in the active phase of induced labour.引产活跃期静脉滴注缩宫素的停用
Cochrane Database Syst Rev. 2018 Aug 20;8(8):CD012274. doi: 10.1002/14651858.CD012274.pub2.
8
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.糖尿病孕妇持续皮下胰岛素输注与多次皮下注射胰岛素的比较
Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3.
9
Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.用于患有已确诊糖尿病/糖耐量受损或既往妊娠糖尿病且计划怀孕的女性,或患有孕前糖尿病的孕妇的口服抗糖尿病药物。
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD007724. doi: 10.1002/14651858.CD007724.pub3.
10
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.

本文引用的文献

1
Increased cesarean section rate and premature birth according to modified WHO maternal cardiovascular risk in pregnant women with congenital heart disease.先天性心脏病孕妇按世界卫生组织改良孕产妇心血管风险评估标准,剖宫产率和早产率增加。
PLoS One. 2023 Nov 16;18(11):e0294323. doi: 10.1371/journal.pone.0294323. eCollection 2023.
2
Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association.心血管疾病孕妇的麻醉护理:美国心脏协会的科学声明。
Circulation. 2023 Mar 14;147(11):e657-e673. doi: 10.1161/CIR.0000000000001121. Epub 2023 Feb 13.
3
Maternal and neonatal outcomes among pregnant women with cardiovascular disease in the Philippines: a retrospective cross-sectional study from 2015-2019.
菲律宾心血管疾病孕妇的母婴结局:2015-2019 年回顾性横断面研究。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9922-9933. doi: 10.1080/14767058.2022.2076590. Epub 2022 May 30.
4
Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.按世界卫生组织孕产妇心血管风险分类标准改良版比较妊娠严重产妇发病率。
Am Heart J. 2022 Aug;250:11-22. doi: 10.1016/j.ahj.2022.04.009. Epub 2022 May 5.
5
Cardiac and Pregnancy Outcomes of Pregnant Patients With Congenital Heart Disease According to Risk Classification System.根据风险分类系统的先天性心脏病孕妇的心脏和妊娠结局。
Am J Cardiol. 2021 Dec 15;161:95-101. doi: 10.1016/j.amjcard.2021.08.037. Epub 2021 Oct 8.
6
Cardiac and obstetric outcomes in pregnant patients with heart disease: a retrospective cohort study.心脏病孕妇的心脏和产科结局:一项回顾性队列研究。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):5140-5148. doi: 10.1080/14767058.2021.1875433. Epub 2021 Feb 25.
7
Position Statement on COVID-19 and Pregnancy in Women with Heart Disease Department of Women Cardiology of the Brazilian Society of Cardiology - 2020.巴西心脏病学会女性心脏病学部关于COVID-19与心脏病孕妇的立场声明 - 2020年
Arq Bras Cardiol. 2020 Nov;115(5):975-986. doi: 10.36660/abc.20201063.
8
Risk factors for cardiac, obstetric, and neonatal complications in patients with heart disease during pregnancy.心脏病患者妊娠时心脏、产科和新生儿并发症的危险因素。
Arch Cardiol Mex. 2020;90(2):101-107. doi: 10.24875/ACME.M20000102.
9
Heart Disease and Pregnancy: The Need for a Twenty-First Century Approach to Care….心脏病与妊娠:需要采用 21 世纪的护理方法……
Heart Lung Circ. 2021 Jan;30(1):45-51. doi: 10.1016/j.hlc.2020.06.021. Epub 2020 Jul 28.
10
Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease - 2020.巴西心脏病学会关于心脏病女性妊娠管理与计划生育的声明 - 2020年
Arq Bras Cardiol. 2020 Jun 1;114(5):849-942. doi: 10.36660/abc.20200406.